REQUEST A QUOTE
REQUEST A QUOTE

Mediate


We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 1 of 1 | Total 8 projects in this tag

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Intermediate Bulk Containers (IBC) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

An intermediate bulk container (IBC) is purpose built tank or container used to store or transport bulk fluid and dry materials. IBC containers are usually made of plastic, steel, or stainless steel and feature cages or bases designed for easy use with material handling vehicles such as forklifts. These containers are commonly used to store a range of materials, including loose components, powdered goods, and liquid soap, as well as food stuffs and hazardous fluids or solids. The advantages of using IBC containers include low transit costs, efficient space utilization during transit or storage, and good compatibility with a range of filling and discharge systems. The intermediate bulk container is used to store and transport a broad range of dry and fluid materials, including hazardous or dangerous goods where approved container types are used. Common intermediate bulk container-stored goods include chemicals and adhesives, liquid soaps, and loose components, as well as sugar and rice. As a matter of fact, IBC containers are suitable for most free-flowing materials. Fluid cargos, particularly hazardous materials, are typically stored and transported in double-walled containers designed to contain spills. The Indian economy is growing and so is the bulk packaging segment of country’s packaging industry. The packaging industry in India has been registering a constant growth rate of 15%. As growth rides on increased industrial production and international trade, demands on bulk package have become more intense and sophisticated. The Indian bulk packaging sector primarily targets meeting the needs of industrial production and bulk wholesale distribution. It is also an essential element of transitional and transport packaging of even retail packs. Price range of IBC’s in India is Rs. 6,000 – Rs. 14,000 and their present usage is around 10,000 units valued at about Rs. 10 crores. Due to demand growth, it is a good project for entrepreneurs to invest. ? Few Indian Major Players are as under:- Hoysala Blow Moulders (India) Ltd. Jumbo Bag Ltd. K R Foods Ltd. Rasik Plast Ltd. Shankar Packagings Ltd. U C L Plastics Ltd.
Plant capacity: 96000 Nos. / AnnumPlant & machinery: Rs. 81 Lakhs
Working capital: -T.C.I: Cost of Project : Rs. 419 Lakhs
Return: 26.00%Break even: 65.00%
Add to Inquiry Add to Inquiry Basket

Dye Intermediates - Indigo Blue

Indigo is an ancient dye, sold as a striking and bold blue crystalline powder. It has been used in many civilizations and was popular in Mayan, Egyptian, Japanese and Indian cultures. Its common use is in creating the popular Shibori and tie dye fabrics as well as denim. Indigo dye is an organic compound with a distinctive blue color (see indigo). Historically, indigo was a natural dye extracted from the leaves of certain plants, and this process was important economically because blue dyes were once rare. A large percentage of indigo dye produced today, several thousand tonnes each year, is synthetic. It is the blue often associated with denim cloth and blue jeans. Indigo is a type of blue dye that is generally used for coloring of cotton yarn that is used for production of denim cloth for blue jeans. Indigo is also used for dyeing wool and silk. Indigo was a natural dye which was extracted from plants but now it is synthetic. Indigo dye is a natural dye that is extracted from plants and animals. Though the dye was and is still produced organically, most of the indigo dye available in the market today is mass produced through chemical processes to satisfy increased demand for blue dye. Increase in demand for dye intermediates in textile and extensive use of dye intermediates in printing inks are some factors driving the dye intermediates market. This is prompting companies to increase production of dye intermediates. Additionally, easy availability of raw materials is anticipated to boost the demand for dye intermediates in the near future. The global dye intermediates market is witnessing technological advancements. Companies are constantly striving to develop new and better ways to manufacture dye intermediates. Development of new manufacturing processes of dye intermediates and applications is estimated to propel the dye intermediates market. However, volatility in prices of raw material is projected to inhibit the market. Based on geography, the dye intermediates market can be segregated into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Asia Pacific is anticipated to constitute a key share of the market during the forecast period. The dye intermediates market in Asia Pacific is estimated to expand a considerable pace owing to the increase in demand for dye intermediates in the paints and printing inks. Middle East & Africa is likely to be an attractive region for the dye intermediates market during the forecast period due to the rise in demand for these in the textile industry in the region.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Dyes & Dye Intermediates

Dyes are used to impart colors to a substance or surface. Dye intermediates are raw materials used to manufacture dyes. Dye intermediates comprise petrochemical products that are processed to manufacture the final dyes and pigments. H-acid (1-amino, 8-napthol, 3, 6-disulfonic acid) is an extensively used dye intermediate. These intermediates are used in the production of hair dyes. Dye intermediates are manufactured from nitro-aromatics, which are manufactured from benzene and toluene. Benzene and toluene are petrochemical downstream products. Therefore, any change in the crude oil prices affects the dye intermediates market significantly. The dye intermediates are a vital inputs for a number of major industries. Some of the major industries they serve are textiles, plastics, paints, printing inks and paper. Dye intermediates are raw materials used to manufacture dyes. Dye intermediates comprise petrochemical products that are processed to manufacture the final dyes and pigments. H-acid (1-amino, 8-napthol, 3, 6-disulfonic acid) is an extensively used dye intermediate. These intermediates are used in the production of hair dyes. Dye intermediates are manufactured from nitro-aromatics, which are manufactured from benzene and toluene. The global market for dyes has been witnessing significant growth due to rising demand from end-user industries such as food, textile, printing inks, and paints & coatings. Developing economies such as China, India, Brazil, and Indonesia are likely to play a substantial role in boosting consumption of dyes in the next few years. India and Indonesia are gradually taking the lead in manufacturing dyes due to availability of raw materials as well as various organic intermediate chemicals. In terms of application, the dye intermediates market can be divided into textiles, plastics, paints, printing inks, paper, and others. The textiles segment of the dye intermediates market is anticipated to expand at a considerable pace due to increasing demand of appeals from the emerging economies. Based on geography, the dye intermediates market can be segregated into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Asia Pacific is anticipated to constitute a key share of the market during the forecast period. The dye intermediates market in Asia Pacific is estimated to expand a considerable pace owing to the increase in demand for dye intermediates in the paints and printing inks. Middle East & Africa is likely to be an attractive region for the dye intermediates market during the forecast period due to the rise in demand for these in the textile industry in the region.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

HDPE Jumbo Bags (Flexible Intermediate Bulk Containers)

Jumbo bags are big bags used for packing bulk materials of different types. These big bags in different specifications and grades based on the requirements of our customers and packaging needs. The jumbo fabrics are made from polypropylene materials that are high durable and flexible for supporting a wide range of packaging applications. The jumbo fabrics can withstand huge capacities ranging from 250 kgs to 2000 kgs. The bags facilitate both manual filling and hopper feeding at filling as well as discharge points; the ability of UV stabilization makes these Jumbo fabrics more highly appreciable. The jumbo bags in different sizes and dimensions in customized ranges, high space availability makes these bags to store bulk materials neatly and effectively. The Indian bulk packaging market started moving significantly only in the 1990s as the industries acquired bulk-handling capabilities to compete in the globalised world. The markets really took off at the turn of the new millennium spurred by an export led and domestic growth in the agro produce & food; bulk drugs & generics; chemicals & pesticides and Petroleum & lubricants. The market grew at around 28% for the first 6-7 years and then settled down to a 15-20 % band largely bucking the worldwide slowdown. The INR 140 bn. flexible bulk packaging industry that includes woven sacks, leno bags, wrapping fabric, and Flexible Intermediate Bulk Container (FIBC) is growing at over 20% with FIBC containers expected to grow three fold in the next 5 years riding an increased industrial production and a shift toward higher-value containers offering enhanced performance and supply chain efficiency. In fact, the global slowdown has been an opportunity for the Indian FIBC manufacturers as the production cuts by the companies in Europe and USA has resulted in the sourcing shifting to India adding an important factor to the growth story.
Plant capacity: 8,640,000 Nos per AnnumPlant & machinery: 106 Lakhs
Working capital: -T.C.I: Cost of Project: 748 Lakhs
Return: 35.00%Break even: 58.00%
Add to Inquiry Add to Inquiry Basket

HDPE Jumbo Bags (Flexible Intermediate Bulk Containers)

Jumbo bags are big bags used for packing bulk materials of different types. these big bags in different specifications and grades based on the requirements of our customers and packaging needs. The jumbo fabrics are made from polypropylene materials that are high durable and flexible for supporting a wide range of packaging applications. The jumbo fabrics can withstand huge capacities ranging from 250 kgs to 2000 kgs. The bags facilitate both manual filling and hopper feeding at filling as well as discharge points; the ability of UV stabilization makes these Jumbo fabrics more highly appreciable. Jumbo bags are big bags used for packing bulk materials of different types. These big bags are manufactured in different specifications and grades based on the requirements of our customers and packaging needs. The jumbo fabrics are made from polypropylene materials that are high durable and flexible for supporting a wide range of packaging applications. The markets really took off at the turn of the new millennium spurred by an export led and domestic growth in the agro produce & food; bulk drugs & generics; chemicals & pesticides and Petroleum & lubricants. The market grew at around 28% for the first 6-7 years and then settled down to a 15-20 % band largely bucking the worldwide slowdown. The INR 140 bn. flexible bulk packaging industry that includes woven sacks, leno bags, wrapping fabric, and Flexible Intermediate Bulk Container (FIBC) is growing at over 20% with FIBC containers expected to grow three fold in the next 5 years riding an increased industrial production and a shift toward higher-value containers offering enhanced performance and supply chain efficiency. Few Indian major players are as under: • Abdos Polymers Ltd. • Agarwal Polysacks Pvt. Ltd. • Anya Polytech & Fertilizers Pvt. Ltd. • Ashoka Poly Laminators Ltd. • Bardanwala Plastics Pvt. Ltd. • Bihar Raffia Inds. Ltd. • Commercial Syn Bags Ltd.
Plant capacity: 12000 Nos. per dayPlant & machinery: 155 Lakh
Working capital: -T.C.I: Cost of Project: 635 Lakh
Return: 31.00%Break even: 49.00%
Add to Inquiry Add to Inquiry Basket

Investment Opportunities in API Bulk Drugs & Intermediates Manufacturing Unit

Investment Opportunities in API Bulk Drugs & Intermediates Manufacturing Unit. Govt Announces Rs. 13,760-Cr Package to Boost API & Medical Device Production in India. Active Pharmaceutical Ingredient (API) API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. For example, an active ingredient to relieve pain is included in a painkiller. This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine. Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Related videos: - Manufacturing Business Ideas in Pharmaceutical Industry Manufacturing of Pharmaceutical Bulk Drugs and Medicine Pharmaceutical Pellets and Granules Pharmaceutical Manufacturing Unit Indian Pharma Industry: An Investment Opportunity Manufacturing Business Ideas in Pharmaceutical Industry Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. List of APIs Products Identified 1) Amoxicillin 2) Azithromycin 3) Erythromycin Stearate/Estolate 4) Ceftriaxone 5) Cefoperazone 6) Cefixime 7) Cephalexin 8) Piperacillin Tazobactam 9) Sulbactam 10) Dexamethasone 11) Prednisolone 12) Metformin 13) Gabapentin 14) Rifampicin 15) Vitamin B1 16) Vitamin B6 17) Clindamycin phosphate 18) Clindamycin HCL 19) Streptomycin 20) Neomycin 21) Gentamycin 22) Doxycycline 23) Potassium clavulanate 24) Oxytetracycline 25) Tetracycline 26) Clarithromycin 27) Betamethasone 28) Ciprofloxacin 29) Losartan 30) Telmisartan 31) Artesunate 32) Norfloxacin 33) Ofloxacin 34) Metronidazole 35) Sulfadiazine 36) Levofloxacin 37) Meropenem 38) Paracetamol 39) Tinidazole 40) Ornidazole 41) Ritonavir 42) Diclofenac Sodium 43) Aspirin 44) Levetiracetam 45) Carbidopa 46) Levodopa 47) Carbamazepine 48) Oxcarbazepine 49) Valsartan 50) Olmesartan 51) Atorvastatin 52) Acyclovir 53) Lopinavir Market in India The Indian pharmaceutical industry is ranked third in the world in terms of production volume and 13th in terms of domestic consumption value. The Indian pharmaceutical industry size is estimated at US$25 billion in 2015. Formulations account for 65% and bulk drugs for the balance 35% in value terms. The industry is expected to reach US$55 billion by 2020. Bulk drug exports are expected to grow the fastest at 14-16% CAGR due to the growing demand of generic products and rising cost pressures that innovators face. Formulation exports are also expected to grow at 14-16% CAGR. API manufacturers in India are making efforts to strengthen their marketing capacity in the regulated markets by improving production yields, modifying production processes, and increasing sales in the international markets. More than 30% of the APIs manufactured in India are exported to countries such as US, UK, Japan, etc. The total production market of API in India was valued at approximately US$ 11 Billion in FY 2016. This market is forecasted to grow at a CAGR of around 9% during the period of FY 2016–FY 2022. Of the total domestic consumption, approximately 32% was imported. Of the total imports, China alone accounts for 57-60% of the APIs imported by India. The remaining imports are from countries such as Italy, Germany, Malaysia, and others. These facts indicate that there is plentiful scope for the domestic API market to grow, if the manufacturers are able to produce the required amount of APIs on their own, rather than importing it from other countries. Indian API Domestic Consumption The Indian API domestic consumption market will grow at a CAGR of around 10% from FY 2016 to FY 2022. Furthermore, the government is also taking various initiatives, such as allocating lands in various states for the development of API Mega Parks, increased investment in R&D, etc. to boost the industry. These initiatives will further propel the growth of the Indian API industry, as well as the domestic market for the APIs. Related Videos: - https://bit.ly/2XVNXsY Key players, such as Sun Pharma, Dr. Reddy’s, Cipla, Aurobindo Pharma, Lupin, etc., are being lured to increase their investment in the Indian API industry by providing them various lucrative offers. Tags:- #API #startupindia #APIBusiness #ActivePharmaceuticalIngredient #Amoxicillin #azithromycint #ErythromycinStearate #ceftriaxone #cefoperazone #cefixime #amoxicillin #doxycycline #cephalexin #ciprofloxacin #clindamycin #metronidazole #azithromycine #Piperacillin #tazobactam #sulbactam #dexamethasone #prednisolone #Metformin #Gabapentin #clindamycin #Clindamycin #Streptomycin #Neomycin #Gentamycin #Doxycycline #Potassiumclavulanate #Oxytetracycline #Tetracycline #Clarithromycin #Betamethasone #Ciprofloxacin #Losartan #Telmisartan #Artesunate #Norfloxacin #Ofloxacin #Metronidazole #Sulfadiazine #Levofloxacin #Meropenem #Paracetamol #Tinidazole #Ornidazole #Ritonavir #Diclofenac Sodium #Aspirin #Levetiracetam #Carbidopa #Levodopa #Carbamazepine #Oxcarbazepine #Valsartan #Olmesartan #Atorvastatin #Acyclovir #Lopinavir #businessopportunity #projectreport #DetailedProjectReport #businessconsultant #businessfeasibilityreport #BusinessPlan #startyourbusiness #investmentopportunity #growyourbusiness #startups #business #covidbusiness #covid19 #covidsmallbusiness
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Investment Opportunities in APIs-KSMs-Drug Intermediates Bulk Drug Industries.

Investment Opportunities in APIs-KSMs-Drug Intermediates Bulk Drug Industries. Cabinet Approves Promotion of Domestic Manufacturing of Critical Key Starting Materials-Drug Intermediates and Active Pharmaceutical Ingredients in the Country. Key Starting Materials (KSMs)/Drug Intermediates KSMs from the essential medicines list for strategic reasons posed by the COVID-19. Role of Government towards (KSMs)/Drug Intermediates The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi has approved the following schemes: The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6, 940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. • Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Impact: Promotion of Bulk Drug Parks: The scheme is expected to reduce manufacturing cost of bulk drugs in the country and dependency on other countries for bulk drugs. Production Linked Incentive Scheme: • The scheme intends to boost domestic manufacturing of critical KSMs/Drug Intermediates and APIs by attracting large investments in the sector to ensure their sustainable domestic supply and thereby reduce India's import dependence on other countries for critical KSMs/Drug Intermediates and APIs. • It will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over 8 years. Implementation: Promotion of Bulk Drug Parks The scheme will be implemented by State Implementing Agencies (SIA) to be set up by the respective State Governments and the target is to set up 3 mega Bulk Drug Parks. Production Linked Incentive Scheme The scheme will be implemented through a Project Management Agency (PMA) to be nominated by the Department of Pharmaceuticals. The Scheme will be applicable only for manufacturing of 53 identified critical bulk drugs (KSMs/Drug Intermediates and APIs). Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Benefits: • Common infrastructure facilities would be created with the financial assistance under the sub-scheme in 03 Bulk Drug Parks. • It is expected to reduce manufacturing cost and dependency on other countries of Bulk Drug in the country. Related videos: - Manufacturing Business Ideas in Pharmaceutical Industry Manufacturing of Pharmaceutical Bulk Drugs and Medicine Pharmaceutical Pellets and Granules Pharmaceutical Manufacturing Unit Indian Pharma Industry: An Investment Opportunity Manufacturing Business Ideas in Pharmaceutical Industry List of Critical KSMs/Drug Intermediates and APIs Fermentation Based 04 KSMs/Drug Intermediates and Corresponding APIs 1. Penicillin G/6-Amino Penicillinc Acid (6-APA) 2. Cephalosporin C/7-Amino Cephalosporanic Acid (7-ACA) 3. Erythromycin Thiocyanate/TIOC 4. Potassium Clavulanate Fermentation Based 10 Niche KSMs/Drug Intermediates and Corresponding APIs 1. Cyclins (Tetracycline, Oxycycline, Doxyxcline) 2. Aminoglycosides (Gentamycin) 3. Aminoglycosides (Neomycin) 4. Aminoglycosides (Streptomycin) 5. Steroids (Betamethasone) 6. Steroids (Dexamethasone) 7. Steroids (Prednisolone) 8. Anti TB (Rifampicin) 9. Vitamins and Nutraceuticals (Vitamin B6) 10. Vitamins and Nutraceuticals (Vitamin B1) Chemical Synthesis Based 04 KSMs/Drug Intermediates and Corresponding APIs (with backward integration) 1. Dicyandiamide (DCDA) 2. Para-aminophenol 3. 2-Methyl -5 Nitro- Imidazole (2-MNI) including Imidazoles. 4. 1, 1 Cyclohexane Diacetic Acid (CDA) Other Chemical Synthesis Based 23 KSMs/Drug Intermediates and Corresponding APIs (with backward integration) 1) Levofloxacin 2) Sulfadiazine 3) Ciprofloxacin 4) Ofloxacin 5) Norfloxacin 6) Artesunate 7) Telmisartan 8) Losartan 9) Valsartan 10) Olmesartan 11) Atorvastatin 12) Acyclovir 13) Lopinavir 14) Ritonavir 15) Oxcarbazepine 16) Carbamazepine 17) Levodopa 18) Carbidopa 19) Levetiracetam 20) Aspirin 21) Diclofenac Sodium 22) Tinidazole 23) Ornidazole Market The Indian pharmaceutical industry is the 3rd largest in the world by volume. However, despite this achievement, India is significantly dependent on the import of basic raw materials, viz., Bulk Drugs that are used to produce medicines. In some specific bulk drugs the import dependence is 80 to 100%. The government has plans to put in place a production-linked incentive (PLI) scheme to boost domestic manufacturing of critical key starting materials (KSMs) or drug intermediates, used to make bulk drugs, as well as APIs. That PLI could cost $911.5 million over the next eight years. India imports 53 APIs and KSMs from China. According to the Trade Promotion Council of India (TCPI), India imports 70% of its API requirements from China, mostly antibiotics and vitamins. In 2018-19, Indian pharma companies imported bulk drugs and intermediates worth $2.4 billion from China. The Indian pharmaceutical market should grow from nearly $34.3 billion in 2020 to more than $45 billion by 2025 million. Quantum of Incentive The fermentation based eligible, incentive for first four years (2022-2023 to 2025-2026) would be 20%, for fifth year (2026-27) incentive would be 15% and the sixth year (2027-2028) incentive would be 5%; on incremental sale of KSMs/Drug Intermediates/APIs. For chemically synthesis eligible products, incentive for five years (2021-2022 to 2025-2026) would be 10% on incremental sales of KSMs/Drug Intermediates/APIs. Tags:- #Levofloxacin #Sulfadiazine #Ciprofloxacin #Ofloxacin #Norfloxacin #Artesunate #Telmisartan #Losartan #Valsartan #Olmesartan #Atorvastatin #Acyclovir #Lopinavir #Ritonavir #Oxcarbazepine #Carbamazepine #Levodopa #Carbidopa #Levetiracetam #Aspirin #Diclofenac Sodium #Tinidazole #Ornidazole #businessopportunity #projectreport #DetailedProjectReport #businessconsultant #businessfeasibilityreport #BusinessPlan #startyourbusiness #investmentopportunity #growyourbusiness #startups #business #covidbusiness #covid19 #covidsmallbusiness #APIBusiness #ActivePharmaceuticalIngredient
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Lucrative Industry of HDPE Jumbo Bags (Flexible Intermediate Bulk Containers)

Jumbo bags are large bags that are used to pack bulk items of various types. These large bags come in a variety of specifications and grades to meet the needs of our customers and their packaging. The jumbo textiles are constructed of polypropylene materials that are extremely resilient and flexible, making them ideal for a variety of packaging applications. Jumbo bags are large bags that are used to pack bulk items of various types. These large bags are produced in a variety of specifications and grades to meet the needs of our customers and their packaging. Jumbo bags are large bags that are used to pack bulk items of various types. These large bags are produced in a variety of specifications and grades to meet the needs of our customers and their packaging. The jumbo textiles are constructed of polypropylene materials that are extremely resilient and flexible, making them ideal for a variety of packaging applications. • Cost-effective • Very sturdy and flexible • Easy to lift thanks to inbuilt lifting loops • A wide range of sizes are available. • A wide range of filling, discharging, and lifting options • FIBCs are lightweight and portable. These bags may be transported in a very straightforward and simple manner thanks to the large range of Lifting Options offered. • FIBCs are available in a variety of sizes and specifications, and are known for their long life and durability. • FIBCs are the most convenient and cost-effective means to carry and transfer bulk goods for export. By 2023, the global bulk bags market is estimated to be worth USD 4956.7 million, increasing at a 6.80 percent compound annual growth rate (CAGR). To replace wood and cardboard, the market demands reusable, recyclable, and contamination-free packaging solutions. Bulk bag producers are encouraged to create innovative solutions in part by the requirement to prevent damage and contamination to FIBC loads, which customers have expressed as a critical necessity. Few Indian Major Players 1. Ashoka Poly Laminators Ltd. 2. Bardanwala Plastics Pvt. Ltd. 3. Commercial Syn Bags Ltd. 4. Eclat Industries Ltd. 5. Hanson Agro Ltd. 6. Indra Industries Ltd. 7. Jagannath Polymers Pvt. Ltd.
Plant capacity: HDPE Jumbo Bags (FIBCS) 6,666.7 Nos Per DayPlant & machinery: 3465 Lakhs
Working capital: -T.C.I: Cost of Project: 38 Lakhs
Return: 26.27%Break even: 36.20%
Add to Inquiry Add to Inquiry Basket

Information
Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 1 of 1 | Total 8 projects in this tag

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top

Search Project Reports & Profiles



Subjects